Sterling Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $696K | Buy |
12,655
+2,157
| +21% | +$119K | 0.01% | 772 |
|
|
2025
Q1 | $742K | Sell |
10,498
-694
| -6% | -$49.1K | 0.01% | 695 |
|
|
2024
Q4 | $736K | Buy |
11,192
+3,993
| +55% | +$262K | 0.01% | 730 |
|
|
2024
Q3 | $506K | Buy |
+7,199
| New | +$506K | 0.01% | 848 |
|
|
2016
Q2 | – | Sell |
-2,445
| Closed | -$202K | – | 933 |
|
|
2016
Q1 | $202K | Buy |
+2,445
| New | +$202K | ﹤0.01% | 864 |
|